NEWSAdvances in knowledge of the structural biology of the RSV surface fusion (F) glycoprotein#RSV #ReSViNET Advances in knowledge of the structural biology of the RSV surface fusion (F) glycoprotein have revolutionized RSV vaccine development by providing a new target for preventive interventions. It is explained in this video, which was made by Djonie Jacobsen; Nienke Mombarg and Charlotte Wiersma, students from De Streek school in Ede, The Netherlands in April 2018.
ReSViNET scale APP for pediatric respiratory assessment is now available
|
Respiratory Syncytial Virus Seasonality: A Global Overview
Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, Mejías A, Baraldi E, Papadopoulos NG, Nair H, Nunes MC, Kragten-Tabatabaie L, Heikkinen T, Greenough A, Stein RT, Manzoni P, Bont L, Martinón-Torres F, ReSViNET RSV infection epidemiology has been the subject of many studies. As novel RSV therapeutics are reaching the final stages of development, the need for epidemiologic data grows. Specifically, seasonality of the virus has a very important role in predicting the epidemic waves. In this article, Martinon-Torres led his ReSViNET colleges to analyse the different patterns and distributions of the RSV worldwide, gathering information from 27 different countries distributed in the five continents. With the inclusion of reports and data mostly from official surveillance programs from the different countries, they manage to produce a powerful, robust, and homogeneous report on global country-specific RSV seasonality. They also conducted a literature review of medical databases to complement and enrich the report and to cover for those areas where there is lack of official surveillance programs on RSV. The inclusion of various maps and tables with specific data on the start, end, peak and duration of the RSV epidemic in the different countries allow the readers to easily grasp the situation of the virus in the world per epidemiological week or month. This article emerges as a powerful tool for future implementation and optimization of local campaigns and protocols for prevention, diagnose and treatment of RSV infections. In collaboration with RESCEU ReSViNET BROCHURE
| ||
about REsvinet
RSV (Respiratory Syncytial Virus) infection is the second most important cause of death during infancy, especially in developing countries. RSV infection has also been linked to an increased risk in the development of chronic airway disease in later life. Therefore, research on RSV is crucial.
In order to improve research on RSV, ReSViNET (Respiratory Syncytial Virus Network) has been established. In this network, expertise and leadership are combined in order to decrease the global burden of RSV. It is our goal to improve knowledge of RSV epidemiology and to develop safe and effective therapeutic and preventive interventions.
In order to improve research on RSV, ReSViNET (Respiratory Syncytial Virus Network) has been established. In this network, expertise and leadership are combined in order to decrease the global burden of RSV. It is our goal to improve knowledge of RSV epidemiology and to develop safe and effective therapeutic and preventive interventions.
